| |
| Magyar Neuroszonológiai Társaság |
|
| 2024 World Pediatrics Conference |
 Rendezvény kezdete: 2024.10.18. | Rendezvény vége: 2024.10.19. |
| Szakterület(ek): Gyermekgyógyászat |
| Tudományos információ: Morris Silvia |
| Munkahely neve: Episirus Scientifica |
| Címe: 19803 3911 Concord Pike, 8030 SMB, 33612 |
| E-mail: pediatrics@episirus.org |
| Szervező: Morris Silvia |
| Munkahely neve: Episirus Scientifica |
| Címe: 19803 3911 Concord Pike, 8030 SMB, 33612 |
| E-mail: pediatrics@episirus.org |
| Helyszín: Japan, 593000 Osaka, Episirus Scientifica |
| A rendezvény Web oldala: https://pediatrics.episirus.org/ |
Episirus Scientifica welcomes you to attend 2024 World Pediatrics Conference (2024WPC) to be held during October 18-19, 2024 in Osaka, Japan around the theme ‘Scientific advancement and exploration in Pediatrics and Neonatology’ accredited with CPD credits which enable the professionals from worldwide to exchange their views on a wide variety of topics affecting child care and those suffering from pediatric diseases around the world. Since Genetic variance, developmental issues and Congenital defects are of a greater concern to pediatricians, we will be exploring more into these fields. This international meet (2024WPC) anticipates hundreds of participants including keynote speakers, Oral presentations by renowned speakers and poster presenters besides delegates around the world. This conference perhaps a giant event that creates an ideal platform to share expertise addressing current advancements involved in Pediatric and Neonatal care. It will be a wonderful opportunity for all the delegates as it provides an international networking opportunity to collaborate with the world-class Pediatric and Medical Associations.
Few Topics which will be covered:
Pediatric Biochemistry
Pediatric Epilepsy
Pediatric Genetics
Neonatology and Pediatric Intensive Care
Pediatric Infectious Diseases
Pediatric Neuroradiology
Child Nutrition
Pediatric Immunology
Pediatric Allergy and Dermatology
Pediatric Cardiology
Pediatric Psychology and Adolescent Medicine
Pediatric Neurology
Pediatric Hematology and Oncology
Pediatric Emergencies and many more
Target Audience:
Pediatrician
Pediatirc Cardiologists
Pediatric Neurologists
Pediatric Researchers
Pediatric Scientists
Pediatric Nurses
Pediatric Dermatologists
Pediatric Faculty
Medical Colleges
Pediatric Physicians
Training Institutes
Industry professionals
Researchers
Fellows or Postdoctoral Students
Therapists
Emeritus
Young Research Scientists
Business Delegates
Medical Students
Device Manufacturing Companies
Pediatric Associations and Societies
|
|
|
 |
| |
| Magyar Neuroszonológiai Társaság |
|
| 2024 World Pediatrics Conference |
| Rendezvény kezdete: 2024.10.18. | Rendezvény vége: 2024.10.19. |
| Szakterület(ek): Gyermekgyógyászat |
| Tudományos információ: Morris Silvia |
| Munkahely neve: Episirus Scientifica |
| Címe: 19803 3911 Concord Pike, 8030 SMB, 33612 |
| E-mail: pediatrics@episirus.org |
| Szervező: Morris Silvia |
| Munkahely neve: Episirus Scientifica |
| Címe: 19803 3911 Concord Pike, 8030 SMB, 33612 |
| E-mail: pediatrics@episirus.org |
| Helyszín: Japan, 593000 Osaka, Episirus Scientifica |
| A rendezvény Web oldala: https://pediatrics.episirus.org/ |
Episirus Scientifica welcomes you to attend 2024 World Pediatrics Conference (2024WPC) to be held during October 18-19, 2024 in Osaka, Japan around the theme ‘Scientific advancement and exploration in Pediatrics and Neonatology’ accredited with CPD credits which enable the professionals from worldwide to exchange their views on a wide variety of topics affecting child care and those suffering from pediatric diseases around the world. Since Genetic variance, developmental issues and Congenital defects are of a greater concern to pediatricians, we will be exploring more into these fields. This international meet (2024WPC) anticipates hundreds of participants including keynote speakers, Oral presentations by renowned speakers and poster presenters besides delegates around the world. This conference perhaps a giant event that creates an ideal platform to share expertise addressing current advancements involved in Pediatric and Neonatal care. It will be a wonderful opportunity for all the delegates as it provides an international networking opportunity to collaborate with the world-class Pediatric and Medical Associations.
Few Topics which will be covered:
Pediatric Biochemistry
Pediatric Epilepsy
Pediatric Genetics
Neonatology and Pediatric Intensive Care
Pediatric Infectious Diseases
Pediatric Neuroradiology
Child Nutrition
Pediatric Immunology
Pediatric Allergy and Dermatology
Pediatric Cardiology
Pediatric Psychology and Adolescent Medicine
Pediatric Neurology
Pediatric Hematology and Oncology
Pediatric Emergencies and many more
Target Audience:
Pediatrician
Pediatirc Cardiologists
Pediatric Neurologists
Pediatric Researchers
Pediatric Scientists
Pediatric Nurses
Pediatric Dermatologists
Pediatric Faculty
Medical Colleges
Pediatric Physicians
Training Institutes
Industry professionals
Researchers
Fellows or Postdoctoral Students
Therapists
Emeritus
Young Research Scientists
Business Delegates
Medical Students
Device Manufacturing Companies
Pediatric Associations and Societies
|
|
|
|
| |
| Magyar Nephrologiai Társaság |
|
| New Era of Drug Discovery and Clinical Trials in Kidney Disease |
| Rendezvény kezdete: 2014.04.03. | Rendezvény vége: 2014.04.06. |
| Szakterület(ek): Nephrologia |
| Helyszín: Olaszország, Bergamo, |
| A rendezvény Web oldala: http://www.isnnexus.org/bergamo |
ISN Nexus Symposium on the New Era of Drug Discovery and Clinical Trials in Kidney Disease, to be held in Bergamo, Italy on April 3-6, 2014.
Abstract Submissions Deadline: January 6, 2014
Early Registration Deadline: January 27, 2014
We are very excited about this program, which will bring together scientists in academia and the pharmaceutical sector, clinicians and regulators, to define new frameworks towards efficient drug discovery and clinical trials in kidney disease.
We are especially pleased to announce that three major regulatory agencies – the FDA, the EMA and the PDMA – will be represented at the symposium, with speakers from all three giving what promises to be fascinating talks.
The Program pillars for his symposium are:
Target validation and rationale behind drug discovery
Efficient, exploratory first-in-human clinical trials for renal drugs
Global networking of clinical trials
New framework of collaboration between academia, pharma and government/regulatory authorities
Topical highlights will include:
New targets relevant to kidney disease
Unmet medical needs
Target validation
Advancement of drug discovery technologies
Exploratory clinical trials
Surrogate biomarkers
Molecular imaging
Monitoring of renal toxicity
Clinical sessions
Clinical end-points
Protocols of clinical trials
The number of newly approved drugs continue to decrease despite a growing number of kidney patients. This Nexus symposium will provide cutting-edge lectures on recent advances in drug discovery and clinical trials kidney disease.
For the most up-to-date information on this Nexus Symposium we encourage you to visit http://www.isnnexus.org/bergamo on a regular basis
We hope to see you in Bergamo, to make this symposium a success, and to help us advance kidney care around the world.
|
|
|
|
| |
| Magyar Nephrologiai Társaság |
|
| New Era of Drug Discovery and Clinical Trials in Kidney Disease |
| Rendezvény kezdete: 2014.04.03. | Rendezvény vége: 2014.04.06. |
| Szakterület(ek): Nephrologia |
| Helyszín: Olaszország, Bergamo, |
| A rendezvény Web oldala: http://www.isnnexus.org/bergamo |
ISN Nexus Symposium on the New Era of Drug Discovery and Clinical Trials in Kidney Disease, to be held in Bergamo, Italy on April 3-6, 2014.
Abstract Submissions Deadline: January 6, 2014
Early Registration Deadline: January 27, 2014
We are very excited about this program, which will bring together scientists in academia and the pharmaceutical sector, clinicians and regulators, to define new frameworks towards efficient drug discovery and clinical trials in kidney disease.
We are especially pleased to announce that three major regulatory agencies – the FDA, the EMA and the PDMA – will be represented at the symposium, with speakers from all three giving what promises to be fascinating talks.
The Program pillars for his symposium are:
Target validation and rationale behind drug discovery
Efficient, exploratory first-in-human clinical trials for renal drugs
Global networking of clinical trials
New framework of collaboration between academia, pharma and government/regulatory authorities
Topical highlights will include:
New targets relevant to kidney disease
Unmet medical needs
Target validation
Advancement of drug discovery technologies
Exploratory clinical trials
Surrogate biomarkers
Molecular imaging
Monitoring of renal toxicity
Clinical sessions
Clinical end-points
Protocols of clinical trials
The number of newly approved drugs continue to decrease despite a growing number of kidney patients. This Nexus symposium will provide cutting-edge lectures on recent advances in drug discovery and clinical trials kidney disease.
For the most up-to-date information on this Nexus Symposium we encourage you to visit http://www.isnnexus.org/bergamo on a regular basis
We hope to see you in Bergamo, to make this symposium a success, and to help us advance kidney care around the world.
|
|
|
|
| |
| Magyar Nephrologiai Társaság |
|
| New Era of Drug Discovery and Clinical Trials in Kidney Disease |
| Rendezvény kezdete: 2014.04.03. | Rendezvény vége: 2014.04.06. |
| Szakterület(ek): Nephrologia |
| Helyszín: Olaszország, Bergamo, |
| A rendezvény Web oldala: http://www.isnnexus.org/bergamo |
ISN Nexus Symposium on the New Era of Drug Discovery and Clinical Trials in Kidney Disease, to be held in Bergamo, Italy on April 3-6, 2014.
Abstract Submissions Deadline: January 6, 2014
Early Registration Deadline: January 27, 2014
We are very excited about this program, which will bring together scientists in academia and the pharmaceutical sector, clinicians and regulators, to define new frameworks towards efficient drug discovery and clinical trials in kidney disease.
We are especially pleased to announce that three major regulatory agencies – the FDA, the EMA and the PDMA – will be represented at the symposium, with speakers from all three giving what promises to be fascinating talks.
The Program pillars for his symposium are:
Target validation and rationale behind drug discovery
Efficient, exploratory first-in-human clinical trials for renal drugs
Global networking of clinical trials
New framework of collaboration between academia, pharma and government/regulatory authorities
Topical highlights will include:
New targets relevant to kidney disease
Unmet medical needs
Target validation
Advancement of drug discovery technologies
Exploratory clinical trials
Surrogate biomarkers
Molecular imaging
Monitoring of renal toxicity
Clinical sessions
Clinical end-points
Protocols of clinical trials
The number of newly approved drugs continue to decrease despite a growing number of kidney patients. This Nexus symposium will provide cutting-edge lectures on recent advances in drug discovery and clinical trials kidney disease.
For the most up-to-date information on this Nexus Symposium we encourage you to visit http://www.isnnexus.org/bergamo on a regular basis
We hope to see you in Bergamo, to make this symposium a success, and to help us advance kidney care around the world.
|
|
|
|
| |
| Magyar Nephrologiai Társaság |
|
| New Era of Drug Discovery and Clinical Trials in Kidney Disease |
| Rendezvény kezdete: 2014.04.03. | Rendezvény vége: 2014.04.06. |
| Szakterület(ek): Nephrologia |
| Helyszín: Olaszország, Bergamo, |
| A rendezvény Web oldala: http://www.isnnexus.org/bergamo |
ISN Nexus Symposium on the New Era of Drug Discovery and Clinical Trials in Kidney Disease, to be held in Bergamo, Italy on April 3-6, 2014.
Abstract Submissions Deadline: January 6, 2014
Early Registration Deadline: January 27, 2014
We are very excited about this program, which will bring together scientists in academia and the pharmaceutical sector, clinicians and regulators, to define new frameworks towards efficient drug discovery and clinical trials in kidney disease.
We are especially pleased to announce that three major regulatory agencies – the FDA, the EMA and the PDMA – will be represented at the symposium, with speakers from all three giving what promises to be fascinating talks.
The Program pillars for his symposium are:
Target validation and rationale behind drug discovery
Efficient, exploratory first-in-human clinical trials for renal drugs
Global networking of clinical trials
New framework of collaboration between academia, pharma and government/regulatory authorities
Topical highlights will include:
New targets relevant to kidney disease
Unmet medical needs
Target validation
Advancement of drug discovery technologies
Exploratory clinical trials
Surrogate biomarkers
Molecular imaging
Monitoring of renal toxicity
Clinical sessions
Clinical end-points
Protocols of clinical trials
The number of newly approved drugs continue to decrease despite a growing number of kidney patients. This Nexus symposium will provide cutting-edge lectures on recent advances in drug discovery and clinical trials kidney disease.
For the most up-to-date information on this Nexus Symposium we encourage you to visit http://www.isnnexus.org/bergamo on a regular basis
We hope to see you in Bergamo, to make this symposium a success, and to help us advance kidney care around the world.
|
|
|
|
| |
| Magyar Nephrologiai Társaság |
|
| New Era of Drug Discovery and Clinical Trials in Kidney Disease |
| Rendezvény kezdete: 2014.04.03. | Rendezvény vége: 2014.04.06. |
| Szakterület(ek): Nephrologia |
| Helyszín: Olaszország, Bergamo, |
| A rendezvény Web oldala: http://www.isnnexus.org/bergamo |
ISN Nexus Symposium on the New Era of Drug Discovery and Clinical Trials in Kidney Disease, to be held in Bergamo, Italy on April 3-6, 2014.
Abstract Submissions Deadline: January 6, 2014
Early Registration Deadline: January 27, 2014
We are very excited about this program, which will bring together scientists in academia and the pharmaceutical sector, clinicians and regulators, to define new frameworks towards efficient drug discovery and clinical trials in kidney disease.
We are especially pleased to announce that three major regulatory agencies – the FDA, the EMA and the PDMA – will be represented at the symposium, with speakers from all three giving what promises to be fascinating talks.
The Program pillars for his symposium are:
Target validation and rationale behind drug discovery
Efficient, exploratory first-in-human clinical trials for renal drugs
Global networking of clinical trials
New framework of collaboration between academia, pharma and government/regulatory authorities
Topical highlights will include:
New targets relevant to kidney disease
Unmet medical needs
Target validation
Advancement of drug discovery technologies
Exploratory clinical trials
Surrogate biomarkers
Molecular imaging
Monitoring of renal toxicity
Clinical sessions
Clinical end-points
Protocols of clinical trials
The number of newly approved drugs continue to decrease despite a growing number of kidney patients. This Nexus symposium will provide cutting-edge lectures on recent advances in drug discovery and clinical trials kidney disease.
For the most up-to-date information on this Nexus Symposium we encourage you to visit http://www.isnnexus.org/bergamo on a regular basis
We hope to see you in Bergamo, to make this symposium a success, and to help us advance kidney care around the world.
|
|
|
|
